http://www.swissfinancezone.com/ http://backend.userland.com/rss/ Swiss Stocks Research Mon, 05 Jan 2009 23:36:57 -0700 Fri, 12 Dec 2008 01:05:50 -0700 XOOPS WhatsNew 2.12 Whats New fm@methodsandtools.com fm@methodsandtools.com Copyright (c) 2009, SwissFinanceZone.com en http://www.swissfinancezone.com/favicon.ico http://www.swissfinancezone.com/ 11 11 http://www.swissfinancezone.com/modules/news/article.php?storyid=104 Active in pharmaceuticals (79% of sales) and diagnostics, Roche specialises in oncology and virology. The Diagnostics division focuses on immunochemicals, blood tests and diabetes care. Roche also owns 55.7% of Genentech and has unrestricted access t ... Fri, 12 Dec 2008 01:05:50 -0700 http://www.swissfinancezone.com/modules/news/article.php?storyid=104 Swiss Market News http://www.swissfinancezone.com/modules/news/article.php?storyid=103 Commerzbank analysts reduce their forecasts for UBS share. They reduced their price target from 19 to 16 CHF. They maintain their HOLD rating. They think that asset outflow will continue in fourth quarter in the private banking unit and prefer Credit ... Fri, 12 Dec 2008 01:01:48 -0700 http://www.swissfinancezone.com/modules/news/article.php?storyid=103 Swiss Market News http://www.swissfinancezone.com/modules/mylinks/singlelink.php?lid=1 The Swiss Exchange's website will be rolling out new content free of charge, spanning current market data and comprehensible neutral business news as well as clever analysis tools. The information on admission and exchange trading can be called up vi ... Fri, 28 Nov 2008 06:33:07 -0700 http://www.swissfinancezone.com/modules/mylinks/singlelink.php?lid=1 Swiss Stocks Links http://www.swissfinancezone.com/modules/news/article.php?storyid=102 Vontobel is relatively cautious on perspectives for the banking sector. Analysts therefore cut price target for Credit Suisse from 53 to 44 CHF and maintain a HOLD rating. Panagiotis Spiliopoulos regrets the high involvement of Credit Suisse in comme ... Fri, 28 Nov 2008 06:26:48 -0700 http://www.swissfinancezone.com/modules/news/article.php?storyid=102 Swiss Market News http://www.swissfinancezone.com/modules/news/article.php?storyid=101 Basilea Pharmaceutica was founded in October 2000 as a spin-off from Roche. (IPO in March 2004). Its R&D department focuses essentially on niche markets (antibiotics, anti-fungal agents, dermatology). The main shareholders are: Basilea itself (tr ... Fri, 28 Nov 2008 06:14:59 -0700 http://www.swissfinancezone.com/modules/news/article.php?storyid=101 Swiss Market News http://www.swissfinancezone.com/modules/news/article.php?storyid=100 Vontobel cuts UBS price target to 22 (30) CHF and recommends to BUY shares. Panagiotis Spiliopoulos has developed a new economic scenario with weaker perspectives for the banking sector. Future EPS have been decreased due to lower assets under manage ... Fri, 28 Nov 2008 06:11:05 -0700 http://www.swissfinancezone.com/modules/news/article.php?storyid=100 Swiss Market News http://www.swissfinancezone.com/modules/news/article.php?storyid=99 Helvetia Holding is a mid-tier Swiss composite insurance company with core competencies in risk management (life and non-life business, reinsurance) and pensions. The life insurance business contributes app. 60% to total premiums written, whereas non ... Fri, 14 Nov 2008 01:43:22 -0700 http://www.swissfinancezone.com/modules/news/article.php?storyid=99 Swiss Market News http://www.swissfinancezone.com/modules/news/article.php?storyid=98 Swisscom (SCMN) reported Q3 headline results which were impacted from higher subscriber acquisition costs regarding profitability: However excluding these impacts the result was broadly in line with expectations. Revenues rose 3.5% YoY to CHF 3.09 b ... Wed, 05 Nov 2008 06:02:47 -0700 http://www.swissfinancezone.com/modules/news/article.php?storyid=98 Swiss Market News http://www.swissfinancezone.com/modules/news/article.php?storyid=97 Adecco reported Q3 2008 results in line with expectations. Despite tough market conditions, the group published Q3 2008 figures in line with market expectations. Sales declined 6% to EUR 5.1 bn. While sales declined only 2% in France and Germany, co ... Tue, 04 Nov 2008 04:35:25 -0700 http://www.swissfinancezone.com/modules/news/article.php?storyid=97 Swiss Market News http://www.swissfinancezone.com/modules/news/article.php?storyid=96 Muttenz, November 4, 2008 – Clariant, a world leader in specialty chemicals, today announced a 5% increase in sales in local currency. Sales in CHF declined 2% due to adverse currency effects and amounted to CHF 6.3 billion compared to CHF 6.4 ... Tue, 04 Nov 2008 00:51:10 -0700 http://www.swissfinancezone.com/modules/news/article.php?storyid=96 Swiss Market News